Morphine Sulfate Injection, Solution
Product Images NDC 0409-2022

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0409-2022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

Chemical structure diagram of Morphine Sulfate, depicting its molecular arrangement including the sulfate and water components (H2SO4 and 5H2O). This structure corresponds to the active ingredient in Morphine sulfate injection solution 50 mg/mL by Hospira, Inc.*

FDA Label Image

Logo (Morphine 02)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Morphine Sulfate Injection, USP 1,000 mg/20 mL (50 mg/mL) single-dose vial label. The product is for intravenous use only after dilution and is not for epidural, intrathecal, or direct injection. Label indicates preservative-free formulation, manufactured by Hospira, Inc., with storage instructions and warning to protect from light and freezing.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Morphine sulfate injection USP, 1,000 mg/20 mL (50 mg/mL) single-dose vial carton label. The label states intravenous use only after dilution and cautions against direct injection and epidural or intrathecal use. Preservative-free with detailed excipient information, storage instructions, and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Morphine sulfate injection, USP 2,500 mg/50 mL (50 mg/mL) in a 50 mL single-dose vial for intravenous use only after dilution. The label states it is preservative-free and cautions against epidural, intrathecal, and direct injection. Distributed by Hospira, Inc., Lake Forest, IL. Includes dosage information, storage instructions, and an NDC 0409-2022-01.*

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Packaging label for Morphine Sulfate Injection, USP 50 mg/mL (2,500 mg/50 mL) single-dose vial by Hospira, Inc. The label indicates intravenous use after dilution, cautions against direct injection, and provides storage and usage instructions. The box also includes NDC 0409-2022-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.